A New Lipid-Lowering Drug Looking For An Indication?

被引:0
|
作者
Barth, Jacques D. [1 ,2 ]
机构
[1] Univ Southern Calif, Keck Sch Med, Cardiol & Prevent Med, Los Angeles, CA 90007 USA
[2] Vitide Med, Clin Res, Santa Monica, CA 90404 USA
来源
关键词
BEMPEDOIC ACID; STATIN; INTOLERANCE;
D O I
10.1016/j.amjcard.2023.09.116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:167 / 168
页数:2
相关论文
共 50 条
  • [21] New lipid-lowering drugs: an update
    Wierzbicki, A. S.
    Hardman, T. C.
    Viljoen, A.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 270 - 280
  • [22] Is the healthy adherer effect present in all the new lipid-lowering drug users?
    Malo, Sara
    Jose Rabanaque, Maria
    Maldonado, Lina
    Moreno, Belen
    Chaure, Armando
    Castel, Sara
    Jesus Lallana, Maria
    Aguilar, Isabel
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (01) : 308 - 308
  • [23] The use of lipid-lowering drug therapy in children and adolescents
    Avis, Hans J.
    Vissers, Maud N.
    Wijburg, Frits A.
    Kastelein, John J. P.
    Hutten, Barbara A.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (03) : 224 - 231
  • [24] LIPID-LOWERING DRUG PRESCRIPTIONS IN A GROUP OF OLOMBIAN PATIENTS
    Machado-Duque, M.
    Machado-Alba, J.
    Gaviria-Mendoza, A.
    VALUE IN HEALTH, 2018, 21 : S96 - S96
  • [25] Women with CHD benefit from lipid-lowering drug
    不详
    JOURNAL OF WOMENS HEALTH, 1997, 6 (03): : 275 - 275
  • [26] Primary prevention lipid-lowering drug therapy - Response
    Gotto, AM
    Kuller, LH
    CIRCULATION, 2002, 106 (07) : E35 - E36
  • [27] Antithrombotic and antiplatelet activities of fenofibrate, a lipid-lowering drug
    Lee, Jung-Jin
    Jin, Yong-Ri
    Yu, Ji-Yeon
    Munkhtsetseg, Tudev
    Park, Eun-Seok
    Lim, Yong
    Kim, Tack-Joong
    Pyo, Myoung-Yun
    Hong, Jin Tae
    Yoo, Hwan-Soo
    Kim, Youngsoo
    Yun, Yeo-Pyo
    ATHEROSCLEROSIS, 2009, 206 (02) : 375 - 382
  • [28] LIFIBROL - A NOVEL LIPID-LOWERING DRUG FOR THE THERAPY OF HYPERCHOLESTEROLEMIA
    LOCKER, PK
    JUNGBLUTH, GL
    FRANCOM, SF
    HUGHES, GS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (01) : 73 - 88
  • [29] What is new in lipid-lowering therapies in diabetes?
    Cheung, Yee-Ming
    O'Brien, Richard
    Ekinci, Elif I.
    INTERNAL MEDICINE JOURNAL, 2019, 49 (12) : 1472 - 1480
  • [30] Alirocoumab: new perspectives of lipid-lowering therapy
    Kobalava, Zh. D.
    Villevalde, S. V.
    Vorobyeva, M. A.
    TERAPEVTICHESKII ARKHIV, 2017, 89 (12): : 114 - 121